Wall Street Breakfast cover image

Jeff Bezos creating AI startup

Wall Street Breakfast

00:00

Novo Nordisk Prices to Challenge Eli Lilly

Kim Kahn outlines Novo Nordisk's price cuts for obesity drugs Lagarv and Ozempic to regain U.S. market share.

Play episode from 01:33
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app